Literature DB >> 1663927

The penetration of sparfloxacin into human plasma and skin tissues.

T Nogita, Y Ishibashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1663927     DOI： 10.1093/jac/28.2.313

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

1.  Tentative interpretive criteria for disk diffusion susceptibility testing of sparfloxacin.

Authors:  P C Fuchs; A L Barry; M A Pfaller
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

2.  Suggested modifications for disk diffusion susceptibility testing criteria for levofloxacin and sparfloxacin following tests with a predictor panel of ciprofloxacin-resistant clinical isolates.

Authors:  L D Sutton; R N Jones
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

Review 3.  Clarithromycin. A review of its pharmacological properties and therapeutic use in Mycobacterium avium-intracellulare complex infection in patients with acquired immune deficiency syndrome.

Authors:  L B Barradell; G L Plosker; D McTavish
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of sparfloxacin.

Authors:  J Shimada; T Nogita; Y Ishibashi
Journal:  Clin Pharmacokinet       Date:  1993-11       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.